HVIVO PLC — Investor Relations & Filings
hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Trading Update | 2026-01-29 | English | |
| Notice of Trading Update | 2026-01-27 | English | |
| Appointment of Non-Executive Director | 2025-12-18 | English | |
| CEO & CFO Share Purchase | 2025-12-15 | English | |
| MSD to acquire Cidara | 2025-11-27 | English | |
| >£5 million CRS contracts signed | 2025-11-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 13646887 | Trading Update | 2026-01-29 | English | ||
| 13384873 | Notice of Trading Update | 2026-01-27 | English | ||
|
2025
13 filings
| |||||
| 10361357 | Appointment of Non-Executive Director | 2025-12-18 | English | ||
| 10159299 | CEO & CFO Share Purchase | 2025-12-15 | English | ||
| 8718291 | MSD to acquire Cidara | 2025-11-27 | English | ||
| 8479091 | >£5 million CRS contracts signed | 2025-11-20 | English | ||
| 8201055 | Positive data from novel human challenge models | 2025-11-11 | English | ||
| 8126007 | Holding(s) in Company | 2025-11-06 | English | ||
| 8067047 | Presentation at Jefferies Healthcare Conference | 2025-11-03 | English | ||
| 11398117 | Holding(s) in Company | 2025-10-27 | English | ||
| 7901772 | Interim results | 2025-09-23 | English | ||
| 7778344 | Notice of Results | 2025-09-04 | English | ||
| 11381141 | Appointment of Non-Executive Chair | 2025-09-01 | English | ||
| 7600122 | Proposed appointment of Chair | 2025-07-29 | English | ||
| 7407625 | H1 Trading update | 2025-07-22 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for HVIVO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
HVIVO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7697/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7697 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7697 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7697 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7697}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HVIVO PLC (id: 7697)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.